APA (7th ed.) Citation

BS, D., CA, M., N, N., S, J. R., R, D., JQ, C., . . . LA, G. (2025). Use of CD19-targeted immune modulation to eradicate AAV-neutralizing antibodies. Molecular therapy : the journal of the American Society of Gene Therapy, 33(7), 3073. https://doi.org/10.1016/j.ymthe.2025.03.003

Chicago Style (17th ed.) Citation

BS, Doshi, et al. "Use of CD19-targeted Immune Modulation to Eradicate AAV-neutralizing Antibodies." Molecular Therapy : The Journal of the American Society of Gene Therapy 33, no. 7 (2025): 3073. https://doi.org/10.1016/j.ymthe.2025.03.003.

MLA (9th ed.) Citation

BS, Doshi, et al. "Use of CD19-targeted Immune Modulation to Eradicate AAV-neutralizing Antibodies." Molecular Therapy : The Journal of the American Society of Gene Therapy, vol. 33, no. 7, 2025, p. 3073, https://doi.org/10.1016/j.ymthe.2025.03.003.